Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
Titel:
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
Auteur:
O'B Hourihane, Jonathan Beyer, Kirsten Abbas, Allyah Fernández-Rivas, Montserrat Turner, Paul J Blumchen, Katharina Nilsson, Caroline Ibáñez, Maria D Deschildre, Antoine Muraro, Antonella Sharma, Vibha Erlewyn-Lajeunesse, Michel Zubeldia, José Manuel De Blay, Frederic Sauvage, Christine D Byrne, Aideen Chapman, John Boralevi, Franck DunnGalvin, Audrey O'Neill, Charmaine Norval, David Vereda, Andrea Skeel, Ben Adelman, Daniel C du Toit, George